Standard BioTools, Inc. (LAB)
0.6276
-0.08
(-11.28%)
USD |
NASDAQ |
Nov 16, 13:35
Standard BioTools Enterprise Value : -155.09M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | -155.09M |
| November 12, 2026 | -177.19M |
| November 11, 2026 | -180.50M |
| November 10, 2026 | -171.82M |
| November 09, 2026 | -160.30M |
| November 06, 2026 | -183.27M |
| November 05, 2026 | -188.63M |
| November 04, 2026 | -191.16M |
| November 03, 2026 | -193.21M |
| November 02, 2026 | -193.57M |
| October 30, 2026 | -193.53M |
| October 29, 2026 | -189.58M |
| October 28, 2026 | -190.76M |
| October 27, 2026 | -191.12M |
| October 26, 2026 | -197.47M |
| October 23, 2026 | -195.26M |
| October 22, 2026 | -183.42M |
| October 21, 2026 | -177.74M |
| October 20, 2026 | -182.75M |
| October 19, 2026 | -180.39M |
| October 16, 2026 | -186.03M |
| October 15, 2026 | -174.43M |
| October 14, 2026 | -184.84M |
| October 13, 2026 | -174.23M |
| October 12, 2026 | -174.66M |
| Date | Value |
|---|---|
| October 09, 2026 | -162.19M |
| October 08, 2026 | -169.73M |
| October 07, 2026 | -166.41M |
| October 06, 2026 | -149.32M |
| October 05, 2026 | -133.14M |
| October 02, 2026 | -140.37M |
| October 01, 2026 | -146.84M |
| September 30, 2026 | -141.98M |
| September 29, 2026 | -168.93M |
| September 28, 2026 | -163.44M |
| September 25, 2026 | -158.50M |
| September 24, 2026 | -157.29M |
| September 23, 2026 | -157.68M |
| September 22, 2026 | -154.62M |
| September 21, 2026 | -157.72M |
| September 18, 2026 | -146.78M |
| September 17, 2026 | -162.38M |
| September 16, 2026 | -170.58M |
| September 15, 2026 | -177.95M |
| September 14, 2026 | -175.52M |
| September 11, 2026 | -178.07M |
| September 10, 2026 | -178.19M |
| September 09, 2026 | -163.56M |
| September 08, 2026 | -177.28M |
| September 04, 2026 | -179.83M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.24B |
| Bio-Rad Laboratories, Inc. | 9.549B |
| Bruker Corp. | 11.01B |
| Danaher Corp. | 186.02B |
| Harvard Bioscience, Inc. | 82.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.98M |
| Revenue (Quarterly) | 19.38M |
| Total Expenses (Quarterly) | 34.36M |
| EPS Diluted (Quarterly) | -0.0419 |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | -77.26% |
| Earnings Yield | -28.17% |
| Normalized Earnings Yield | -18.18 |